Exhibit 10.51

 

CONFIDENTIAL TREATMENT REQUESTED

 

INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND
NOTED WITH “****”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED
TO THE SECURITIES AND EXCHANGE COMMISSION.

 

Lantheus Medical Imaging, Inc.
331 Treble Cove Road
North Billerica, MA 01862

 

February 6, 2014

 

Pharmalucence, Inc.

29 Dunham Road

Billerica, MA 01862

Attention:

Edward J. Connolly,

 

Chief Operating Officer

 

Re:                           Letter Agreement Imposing **** Obligations
(this “Letter Agreement”)

 

Dear Edward:

 

In connection with our companies’ partnership under the long-term Manufacturing
and Supply Agreement by and between Pharmalucence, Inc. (“CMO”) and Lantheus
Medical Imaging, Inc. (“LMI”), dated as of November 12, 2013 (as may be amended,
modified or supplemented from time to time, the “Agreement”), the Parties desire
to amend the Agreement to provide for **** obligations, as follows:

 

1.              No Hire and Non-Solicitation.  The Agreement is hereby amended
by providing for a new Section 6.2(d) that states as follows:

 

During the term of this Agreement and for **** thereafter, each Party hereby
agrees not to (and agrees to cause its controlled affiliates not to), ****.

 

2.              Miscellaneous.  Capitalized terms used but not defined in this
Letter Agreement shall have the meanings ascribed to those terms in the
Agreement.  Article 9 of the Agreement (entitled “Miscellaneous”) is hereby
expressly incorporated by reference into this Agreement.  The Parties
acknowledge and agree that, except as expressly amended by this Letter
Agreement, the Agreement (as so amended) remains in full force and effect in
accordance with its terms.

 

Please confirm your company’s agreement with the terms and conditions of this
Letter Agreement by countersigning two copies of this letter and returning one
fully executed copy to my attention.

 

[The remainder of this page is left blank intentionally.]

 

--------------------------------------------------------------------------------

 

IN WITNESS WHEREOF, the Parties have caused this Letter Agreement to be executed
by their respective duly authorized representatives as of the date first above
written.

 

 

Lantheus:

 

 

 

LANTHEUS MEDICAL IMAGING, INC.

 

 

 

 

 

 

 

By:

/s/ William C. Dawes Jr.

 

Name:

William C. Dawes Jr.

 

Title:

V.P. MFG + OPS

 

 

 

Pharmalucence:

 

 

 

PHARMALUCENCE, INC.

 

 

 

 

 

 

 

By:

/s/ Edward J. Connolly

 

Name:

Edward J. Connolly

 

Title:

COO

 

--------------------------------------------------------------------------------